Global transmission of oseltamivir-resistant influenza.

  • A. A. Moscona
  • Published 2009 in The New England journal of medicine


953 S from one influenza season to the next, we have lost the use of our leading antiviral influenza drug because of resistance. This winter, the circulating strain of seasonal influenza A virus (H1N1) is resistant to the neuraminidase inhibitor osel tamivir. Moreover, rather than emerging under selective pressure of drug use, as many antibiotic-resistant… (More)
DOI: 10.1056/NEJMp0900648


Blog articles referencing this paper